期刊文献+

野生型抑癌基因PTEN真核表达载体的构建及鉴定 被引量:4

Construction and identification of eukaryotic vector incorporated with wild-type PTEN
下载PDF
导出
摘要 目的:构建野生型PTEN基因真核表达载体pcDNA3.0PTEN,并进行鉴定。方法:参照野生型PTEN基因mRNA全序列,在cDNA两端各设计一条对应引物,并引入各自的酶切位点。从正常人外周血淋巴细胞中提取mRNA作为模板合成PTENcDNA第一链,并扩增目的基因全表达序列片段,经双酶切后定向克隆至pcDNA3.0真核表达载体中,蓝白斑试验筛选阳性重组质粒。分别经双酶切、特异PCR及测序法对重组质粒进行鉴定。结果:双酶切和特异PCR结果表明克隆的基因片段约为1.2kb;测序法进一步证实该基因为野生型PTEN编码基因,经NCBIBLAST分析与GenBank中PTEN基因序列同源性为99.92%,编码的氨基酸同源性为100%。结论:成功构建了PTEN真核表达载体pcDNA3.0PTEN,为研究PTEN在肿瘤发生发展中的作用奠定了基础。 Aim: To construct and identify the eukaryotic vector incorporated with wild-type PTEN (pcDNA 3. 0PTEN). Methods: A pair of primers matching the each end of PTEN cDNA and supplemented with appropriate endonuclease sites were designed according to the sequence published in NCBI GenBank, The PTEN mRNA was extracted from peripheral blood lymphocytes, and used as the template to synthesize the first strand of PTEN cDNA. The PTEN gene with complete expression sequence was amplified, which was cloned into pcDNA 3.0 vector after being double-dlgested by endo- nucleases. The recombirlants were identified with double-endonuclease digestion, specific PCR and sequencing. Results: The results of double-endonuclease digestion and specific PCR showed that a 1.2 kb fragment had been cloned into pcDNA 3.0 vector, which was further identified by sequencing and NCBI BLAST analysis. Conclusion: pcDNA 3.0-PTEN has been successfully constructed which may provide the base for further study of PTEN in tumorigenesis mechanism.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2005年第6期1024-1028,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 "211工程"重点项目 教重办(2002)第2号
关键词 PTEN 抑癌基因 真核表达载体 PTEN tumor suppressor gene eukaryotic vector
  • 相关文献

参考文献12

  • 1沈丽佳,谢思明,殷操,阮萍,姚希.抑癌基因PTEN和FHIT在口腔鳞癌中的表达及其与cyclin D1的相关性[J].第一军医大学学报,2005,25(1):79-82. 被引量:14
  • 2于林君,祝善俊,周裔忠,王江,田颖.PTEN负性调控血管紧张素Ⅱ刺激所致心肌细胞肥大[J].第三军医大学学报,2005,27(10):975-977. 被引量:1
  • 3Hlobilkova A, Knillora J, Bartek J, et al. The mechanism of action of the tumor suppressor gene PTEN. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2003,147 (1) :19.
  • 4Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275(5 308): 1943.
  • 5Radu A, Neubauer V, Akagi T, et al. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mlo Cell Biol, 2003,23(17):6139.
  • 6Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet, 2002,70(4) :829.
  • 7Zheng HC, Sun JM, Li XH, et al. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int, 2003, 53(10) :659.
  • 8Tachibana M, Shibakita M, Ohno S, et al. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer, 2002,94(7):1955.
  • 9Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol, 2001,14(7) :672.
  • 10Leslie NR, Downes CP. PTEN function: how normal cells control it and tumour cells lose it. Biochem J, 2004,382(Pt1) :1.

二级参考文献16

  • 1Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC 1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997, 15(4):356-62.
  • 2Van Heerden W F, Swart T J, Robson B, et al. FHIT RNA and protein expression in oral squamous cell carcinomas [J]. Anticancer Res, 2001, 21 (4A): 2425-8.
  • 3Chen Q, L.P. Samaranayake LP, Zhou H, et al. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma[J]. Oral Oncol, 2000, 36(1): 95-9.
  • 4van Heerden WF, Swart T J, Robson B, et al. FHIT RNA and protein expression in oral squamous cell carcinomas [J]. Anticancer Res,2001, 21 (4A): 2425-8.
  • 5Ohta M, Inoue H, Cotticelli M G, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma associated t (3;8) breakpoint, is abnormal in digestive tract cancers [ J ]. Cell, 1996,84(4): 587-97.
  • 6Lee JI, Soria J C, Hassan K. Loss of ghit rxpression is a predictor of poor outcome in tongue cancer [ J ]. Cancer Research, 2001, 61: 837-41.
  • 7Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells[J]. Cancer Res, 1998, 58(22): 5002-8.
  • 8Barne S, Larry D, Garriso N, et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′, 5"-P1, P3-triphosphate hydrolase [J ].Biochemistry, 1996, 35(36): 11529-35.
  • 9Hardt S E,Sadoshima J.Negative regulators of cardiac hypertrophy[J].Cardiovasc Res,2004,63(3):500-509.
  • 10Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancer[J].Science,1997,275(5308):1943-1947.

共引文献13

同被引文献52

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部